FDA Issues Draft Guidance on Latex-Free Claims in Medical Product Labeling
The Food and Drug Administration announced the availability of a draft guidance on medical product labeling related to latex content. FDA said it issued the guidance because manufacturers have included terms like “latex-free” or “does not contain latex” on medical…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
product labeling, but such statements are not specific enough, not scientifically accurate, and should not be included in medical product labeling, the agency said. The guidance recommends accurate labeling that can be used by manufacturers that which to convey no natural rubber was used in a product. Comments on the guidance are due by June 10.